Methods and apparatus for magnet-induced compression anastomosis between adjacent organs

Information

  • Patent Grant
  • 11998207
  • Patent Number
    11,998,207
  • Date Filed
    Monday, October 14, 2019
    5 years ago
  • Date Issued
    Tuesday, June 4, 2024
    6 months ago
Abstract
Methods and apparatus for creating an anastomosis or fistula between the gallbladder and an adjacent organ are disclosed. First, a parent magnet, typically a permanent magnet, is deployed in the stomach, small intestine, or another organ adjacent to the gallbladder, and a mating daughter material is deployed in the gallbladder in order to create a magnet-compression anastomosis. The gallbladder may then be ablated or otherwise functionally inactivated through the anastomosis. Another aspect of the invention relates to an all-in-one surgical kit that contains all the necessary specialized tools for a surgeon to perform the procedure.
Description
FIELD OF THE INVENTION

In general, the invention relates to surgical methods, apparatus and kits. More particularly, the invention relates to methods, apparatus and kits for magnet induced compression anastomosis.


BACKGROUND OF THE INVENTION

Current approaches to surgical treatments for gallbladder disease include open surgical resection, laparoscopic resection, and most recently natural orifice transluminal endoscopic surgery. The risks of these aforementioned techniques include the risks of trans-abdominal and/or transluminal incision (bleeding, infection, perforation, post-operative pain, adhesions, incisional hernia, risks of anesthesia).


Endoscopic approaches to treat gallbladder or biliary disease have been previously reported. Cholecystogastrostomy creation using endoscopic ultrasound assisted T-tag placement has been described. This technique requires breach of the gastric and gallbladder walls.


Another technique has utilized neodymium magnets for the creation of magnet compression anastomosis between the common bile duct and the small intestine. However, this treats obstruction of the common bile duct and does not address alternative gallbladder access, nor does it treat gallbladder disease per se.


A clinical need thus exists for a more minimally invasive procedure and enabling technology which will facilitate the creation of anastomosis between two adjacent organs in the gastrointestinal tract to create an opening between said organs as a replacement procedure for laparoscopic cholecystectomy and/or cholecystogastrostomy.


SUMMARY OF THE INVENTION

Aspects of the invention relate to materials, apparatus, methods, and kits for creating a fistula, anastomosis, or opening between two adjacent organs. In particular embodiments, the organs are adjacent gastrointestinal organs, such as, for example, the stomach and the gallbladder, the small intestine and the gallbladder, the stomach and the duodenum, or the ileum and the colon.


The present invention involves the use of a parent magnet and one or more daughter magnets. The parent magnet can be a permanent rare-earth disc or ring magnet (e.g., neodymium-boron-iron (NdBFe) or samarium-cobalt (SmCo), of the appropriate size and/or shape to fit within an endoscope, catheter, or other surgical instrument. Preferably, the parent magnet is a permanent magnet in the form of a disc with a diameter between 0.5 cm to 6 cm, e.g., 1 cm to 3 cm. The parent magnet can include a magnetic portion adapted to generate a magnetic field, and an attachment portion connected to the magnetic portion. In such embodiments, the attachment portion is preferably constructed and adapted to attach the parent magnet to a tissue. For example, the attachment portion can be an endoscopic clip or a suture.


The daughter magnets or magnetic materials are responsive to the magnetic field of the parent magnet so as to be attracted to the parent magnet through one or more tissues of varying degrees of thickness. The one or more daughter magnets or magnetic materials can include a plurality of ferromagnetic steel ball-bearings or discs. Alternatively, the daughter magnet(s) can be in the form of a magnetic slurry or paste. In a particular embodiment, the one or more daughter magnets are separate magnetic components that are adapted to self-assemble into a larger magnetic structure. The daughter magnet(s) or magnetic materials are appropriately sized and/or shaped for delivery into an organ through an endoscopic instrument and/or system, or a catheter, such as a biliary catheter.


Both the parent and daughter magnets may be made of a biocompatible material or coated with respective biocompatible coatings.


One aspect of the invention involves an apparatus for creating a fistula or an anastomosis between two adjacent organs, such as the stomach and the gallbladder, the small intestine and the gallbladder, stomach and the duodenum, or the ileum and the colon. The apparatus includes a parent magnet having a magnetic portion for generating a magnetic field and an attachment portion connected to the magnetic portion for attaching the parent magnet to a tissue, as described herein. The parent magnet is preferably appropriately sized and shaped, as described herein, for fitting within an endoscope or a catheter. The apparatus further includes one or more daughter magnets or magnetic materials, as described herein, that are responsive to the magnetic field generated by the parent magnet so as to be attracted to the parent magnet through one or more tissues of varying degrees of thickness.


Other aspects of the invention involve the use and placement of a parent magnet or magnetic assembly, as described herein, within a first organ, and the use and placement of one or more daughter magnets or magnetic materials, as described herein, within a second organ adjacent to the first organ. One aspect of the invention involves a method for creating a compression anastomosis between a gallbladder and an adjacent organ, such as the stomach or the small intestine, by placing a parent magnet within the adjacent organ such that it positioned against the proximate wall of the organ that is adjacent to the gallbladder, and introducing one or more daughter magnets or magnetic materials into the gallbladder such that the one or more daughter magnets are magnetically attracted to the parent magnet in the adjacent organ through a defined tissue area between the combined thickness of the two organ walls. The parent magnet may, for example, be introduced by an endoscope, while the daughter magnets or magnetic materials may be introduced into the gallbladder by a catheter, such as a biliary catheter. In alternate embodiments, the daughter magnets or magnetic materials are injected from an adjacent organ (e.g., the stomach or small intestine) into the gallbladder under the guidance of a visualization technology, such as endoscopic ultrasound. For example, endoscopic ultrasound may be used to inject the daughter magnets from the stomach (or the small intestine), through the combined thickness of the stomach wall (or intestinal wall) and the gallbladder wall, into the gallbladder, via the use of Endoscopic Ultrasound, Fine Needle Aspiration (EUS FNA) or other such techniques known to persons skilled in the art of diagnostic and therapeutic endoscopy. Once the parent and daughter magnets have been positioned within their respective organs, they are left in place for a defined amount of time, exerting compressive magnetic forces on the tissue walls, until the tissue necroses and an opening, anastomosis, or fistula is formed between the two adjacent organs.


Another aspect of the invention involves a method for at least partially inactivating a gallbladder by placing a parent magnet proximate to a wall of an adjacent organ proximate to the gallbladder (e.g., the stomach or the small intestine), introducing one or more daughter magnets or magnetic materials into the gallbladder such that the one or more daughter magnets are magnetically attracted to the parent magnet in the adjacent organ through a defined tissue area between the combined thickness of the two organ walls, allowing the tissue in the defined area to necrose to create an anastomosis between the gallbladder and the adjacent organ, removing the first magnet and one or more second magnets, then selectively inducing gallbladder scarring or damage through the anastomosis. The parent magnet may be introduced by an endoscope, while the daughter magnets or magnetic materials may be introduced into the gall bladder by a catheter, such as a biliary catheter, or injected from an adjacent organ (e.g., the stomach or small intestine) into the gallbladder via the use of Endoscopic Ultrasound, Fine Needle Aspiration (EUS FNA) or other such techniques known to persons skilled in the art of diagnostic and therapeutic endoscopy.


Kits according to embodiments of the invention may include, for example, a parent magnet as described herein and one or more daughter magnets or magnetic materials as described herein, the one or more daughter magnets or materials being preloaded into an introducing device such as a biliary catheter, or an endoscope such as an endoscopic ultrasound guided fine needle aspiration needle and/or system. Optionally, the kit(s) of the invention can include a grasping snare or pinchers.


Other aspects, features, and advantages of the invention will be set forth in the description that follows.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be described with respect to the following drawing figures, in which:



FIG. 1 is a schematic illustration of the gallbladder, generally illustrating the positioning of parent and daughter magnets to create a compression anastomosis, and particularly, the delivery of daughter magnetic material through a biliary catheter to the gallbladder.



FIGS. 2A-2E are radiographic views illustrating the deployment and retrieval of parent and daughter magnets to create an anastomosis between the gallbladder and the stomach.



FIGS. 3A-3D are schematic views of a plurality of magnets in the lumen of a catheter, illustrating the process of magnetic self-assembly as the magnets are ejected from the catheter.



FIG. 4 depicts the arrangement for self alignment between assembled parent and daughter magnets using north/south attractive magnet forces.



FIG. 5 depicts the arrangement for self alignment between assembled parent and daughter magnets, using “east/west” attractive magnetic forces.



FIGS. 6A-6D illustrates the concept of “Magnet Self Assembly” in a connected train of magnetic components including a combination of quadruple and dipole components.



FIG. 7 depicts the extrusion of magnet components arranged in “North-South” arrangement from a fine needle aspiration (FNA) needle.



FIG. 8 depicts the self-assembly of the magnetic components depicted in FIG. 7 after extrusion from FNA needle and the use of a suture to connect the magnetic components.



FIG. 9 depicts the deployment of daughter magnets from the stomach into the gallbladder using endoscopic ultrasound, the assembly of the daughter magnets in the gallbladder, and the positioning of a suture in the stomach upon retraction of the endoscopic ultrasound scope.



FIG. 10 depicts the assembly of daughter magnets in the gallbladder, the deployment and assembly of a parent magnet in the stomach, and the positioning of a suture connecting the daughter magnet assembly and the parent magnet assembly.



FIG. 11 depicts the magnetic attraction of daughter magnet assembly positioned against the wall of a gallbladder and a parent magnet positioned against an adjacent stomach wall.





DETAILED DESCRIPTION

The present invention is based on the discovery that an opening may be created in an organ wall or sheet of tissue using magnets. For example, a compression anastomosis or fistula may be created between adjacent abdominal/gastrointestinal organs, such as for example, the stomach and the gallbladder, the small intestine and the gallbladder, the stomach and the duodenum, or the ileum and the colon, using magnets. As used herein, the term “compression anastomosis” refers to the procedure of compressing together the walls of adjacent organs to induce a necrosis/healing process leading to the joining of the lumina of the two organs. The term “fistula” refers to an artificial or abnormal connection or passageway between two epithelium-lined organs that are not normally connected.



FIG. 1 is a schematic illustration of the gallbladder, showing a parent magnet on one side of the organ wall and a daughter magnet, made of a paramagnetic or ferromagnetic material, on the other side of the organ wall. In the illustrated scenario, the parent magnet resides on or is secured to the stomach wall (not shown in FIG. 1). Once installed, the parent magnet and daughter magnet are left in place, with the magnetic attractive forces between them compressing the organ wall or walls, until an opening or anastomosis is created.


The parent magnet may, for example, comprise a permanent magnet such as a rare-earth disc or ring magnet (e.g., neodymium-boron-iron (NdBFe) or samarium-cobalt (SmCo) attached to a means of mucosal or tissue fixation, such as an endoscopic clip (Olympus QuickClip 2 Hemostatic Clip device, Olympus Corporation, Tokyo, Japan), via a connection, such as suture. In some embodiments, the parent magnet is large enough and of a shape appropriate to create an opening of a size and shape sufficient for an endoscope, catheter, or other surgical instrument to pass through. For example, in the embodiment of FIG. 1, the parent magnet is in the form of a disc with a diameter between 0.5 cm to 6 cm, but with a preferable diameter of 1 cm to 3 cm. This range of diametric sizes creates an anastomosis large enough to avoid stricture formation that may prohibit endoscopic access.


One advantage of systems, methods, and kits according to embodiments of the invention is that the parent magnet and the daughter magnet need not be of the same shape, size, or characteristics. For example, the parent magnet may be relatively larger and adapted for delivery using one type or size of instrument, while the daughter magnet or magnets may be of a different form and adapted for delivery using a different type of instrument.


The one or more daughter magnets or magnetic materials can include a plurality of paramagnetic or ferromagnetic steel ball-bearings or discs having a sufficient size and/or shape for delivery by syringe using air or water pressure through an endoscopic biliary catheter, or a fine needle aspiration needle. For example, The bearings or discs may small enough to be deployed endoluminally via the cystic duct or can be endoscopically injected directly into the gallbladder from an adjacent organ (e.g., the stomach) with the aid of endoscopic ultrasound (EUS) techniques, such as, for example, Endoscopic Ultrasound, Fine Needle Aspiration (EUS FNA). This technique differs from a conventional cholecystogastrostomy using T-tags because the fistula is created by means of magnetic anastomosis rather than endoscopic suturing. In an alternative embodiment, the one or more daughter magnets or magnetic materials can include a magnetic slurry or paste.


The parent and daughter magnets or magnetic materials would generally be made of a biocompatible material or coated with a biocompatible coating, such as Parylene (Specialty Coating Services (SCS), Indianapolis, IN) or other biocompatible coating materials, known to persons skilled in the art.


The drawings depicted in FIGS. 2A-2E are views illustrating by example, the deployment and retrieval of parent and daughter magnets to create an anastomosis between the gallbladder and the stomach. Specifically, FIGS. 2A and 2B show deployment of paramagnetic 52100 steel ball-bearings into the gallbladder via a biliary catheter. FIG. 2C shows deployment of a NdBFe parent magnet which is endoscopically clipped to the stomach wall. Capture of the bearings, shown in FIGS. 2D and 2E, by the parent magnet, results in apposition of the daughter and parent magnets for the anastomosis.


In another embodiment of the invention, the daughter magnet or magnetic material, which may be used as the intra-gallbladder component in a stomach-gallbladder anastomosis, comprises a second rare-earth magnet that can be delivered by syringe using air or water pressure through an endoscopic biliary catheter or endoscopically injected into the gallbladder from an adjacent organ (e.g., the stomach) with the aid of EUS FNA methodologies. Since the size of any one daughter element is limited by the cystic duct diameter, this embodiment may utilize a “self-assembling” structure for the magnetic elements, such that after deployment into the gallbladder, the daughter magnet's elements combine to form a larger structure, thus creating sufficient force between the parent and daughter magnets to result in anastomosis. This type of magnetic self-assembly is schematically illustrated in FIGS. 3A-3D, in which a train of daughter magnet components are injected into the gallbladder.


The components each carry two miniature magnets of variable magnetic polarity (e.g., north (N) or south (S)). In the case of quadrapolar magnets, three magnet component combinations are possible: (i) N-N, (ii) S-S and (iii) N-S (which is equivalent to S-N upon rotation by 180° for symmetric components). The daughter magnet components are small enough to fit through the inner diameter of the biliary catheter or EUS FNA device or FNA needle. Careful selection of the injection sequence can yield a larger planar surface upon self-assembly within the gallbladder than would be possible with any single component. The large daughter magnet in FIG. 3D is assembled by means of the following magnet component sequence (leftmost polarity first): N-S, NN, N-S, N-N. FIGS. 3A-3D represent the simplest example of magnetic self-assembly, and a much larger number of daughter magnet components can be used in practice to provide sufficient mating area with the parent magnet in the small intestine or stomach wall for effective anastomosis.


The simplest embodiment of a self-assembling magnet results from a dipolar train of free (i.e. unconnected) rectangular or cylindrical magnets extruded into space where the direction of magnetic polarization is perpendicular to the direction of extrusion and the magnetization direction increases in consecutive components by 90° with each. For four rectangular components, where the direction of magnetization of consecutive components is 0°, 90°, 180° and 270° in the plane perpendicular to extrusion, the resultant assembly will be a four-sided rectangle (or a square in the case of identical components), as shown in FIG. 4. If this first magnetic train comprises the daughter magnet and a second, identical magnetic assembly comprises the parent magnet then mating occurs when the two opposing pole faces (i.e., north and south in the case of FIG. 4) come into proximity and the magnetic attractive forces between the two assemblies cause compressive attraction between the parent and daughter magnets. This compressive attraction which acts to compress the intervening gastric and gall bladder walls is theoretically sufficient to produce a leak-free magnetic anastomosis within a period of three to five days. The resultant window of access is accessed by means of needle-knife incision or similar endoscopic cautery, known to persons skilled in the art.



FIG. 4 shows the arrangement for self alignment between assembled parent and daughter magnets, using purely north/south attractive magnet mating. This configuration is suitable for generating significant compressive force sufficient for the creation of magnetic anastomosis using NdFeB magnetic components. However, to avoid repulsion between the parent and daughter assemblies, the opposing faces (i.e., north/south) need to be in closest contact.



FIG. 5 shows the arrangement for self alignment between assembled parent and daughter magnets, using what we term “east/west” attractive magnetic forces. This attraction takes advantage of the necessity for magnetic flux lines to form closed paths leading to a strong compressive force between the parent and daughter assemblies. While necessarily less than the compressive force for purely N/S attraction, this configuration may also be suitable for generating significant compressive force sufficient for the creation of magnetic anastomosis using NdFeB magnetic components when the separation distance is small (<1 mm) and high grade magnetic components (e.g., N50 or higher) are employed. The advantage of this configuration is that compression occurs independent of which faces are in contact and self alignment is again achieved.



FIG. 6 illustrates the concept of “Magnet Self Assembly” in a connected train of magnetic components. When a combination of quadruple and dipole components are employed, a repulsive magnetic force can be used to ensure self assembly. As shown in FIG. 6, the self assembly is due to the repulsive forces associated with neighboring S poles (indicated by the solid circles) in the upper two components and the neighboring N poles (indicated by the crosses) in the lower two components which, together, drive the assembly into the final four-sided window.


In an alternate embodiment of the present invention, the intra-gallbladder daughter material may comprise a (super)paramagnetic fluid consisting of iron-oxide particles or a suspension of iron filings. In the presence of the parent magnet, the (super)paramagnetic fluid would be strongly attracted to the parent magnet again, resulting in anastomosis due to the pressure between the two surfaces.


When external magnets are applied to the ferromagnetic daughter material they can be permanently magnetized to enhance the force of attraction between the parent magnet and the daughter material.


In the case of a stomach-gallbladder anastomosis, the parent magnet may be placed on the lumen of the small intestine or on the stomach wall using an endoscope that is introduced per-orally. The parent magnet may be fixed to the mucosa of the small intestine or stomach using an endoscopic clip.


One method for deploying the daughter magnet or magnetic material would involve using the standard Endoscopic Retrograde Cholangiopancreatography (ERCP) technique and fluoroscopy, in which a biliary catheter is introduced over a guidewire into the gallbladder. The ball-bearings or other daughter magnetic material would be delivered to the gallbladder through the biliary catheter using air pressure or liquid pressure provided by syringe. Alternatively, the daughter magnet or magnetic material may be deployed by direct injection from an adjacent organ into the gallbladder with the aid of EUS FNA type systems.


As previously stated, the magnets may be delivered from one organ (e.g., the stomach) into another adjacent organ (e.g., the gallbladder) via a Fine Needle Aspiration (FNS) needle as illustrated in FIGS. 7 and 8. In this alternate embodiment, the individual magnets are circular in nature and pre-assembled in a N-S arrangement and injected through the inner lumen of the needle under endoscopic ultrasound guidance. These magnets may also be polarized in a N-S arrangement around the circumference of the magnet to provide for a means of apposition with the parent magnet once positioned. The distal and proximal magnets are pre-loaded with a suture through the distal and proximal eyelets of the distal and proximal magnet elements respectively. Once injected through the needle or biliary catheter, the distal and proximal magnet elements are secured together by tying off the pre-attached suture. As shown in FIG. 9, the suture is connected at the distal end to the deployed magnetic daughter assembly and runs antegrade through the inner lumen of the aspiration needle or biliary catheter. Once the needle is retracted through the wall of the stomach, the suture remains connected at the proximal end to the parent magnet assembly as shown in FIGS. 9 and 10. Once the parent magnet has been deployed into the stomach or other organ, both daughter and parent magnets are pushed together to great a tissue apposition between gallbladder and stomach as shown in FIG. 11.


Once deployed, magnet fixation is then achieved using EUS-guided T-tag delivery through the gallbladder wall with a second attachment to parent magnet in the stomach or small intestine, ensuring lock-in of parent magnet to the daughter. Such a T-tag procedure is well known to persons skilled in the art of therapeutic endoscopy. Using fluoroscopic guidance, magnetic attraction between the parent magnet and the intra-gallbladder ball-bearings can then be confirmed.


When the parent and daughter magnets are left in place for a period of time, the compressive forces on the tissue between the two magnets causes the tissue to necrose, leaving an opening surrounded by a fibrotic or collagenous border. After a period of several days (3-15), the creation of an opening, such as a cholecystogastrostomy, can be confirmed by upper endoscopy or another such technique. At that time, the cholecystogastrostomy can be traversed using the upper endoscope for the purpose of mucosal ablation. Mucosal ablation may be achieved using argon plasma coagulation (APC), electrocautery, laser, or instillation of sclerosant (e.g. alcohol or ethanolamine or sodium morrhuate). A prophylactic biliary stent may optionally be placed by endoscopic retrograde cholangiopancreatography (ERCP) prior to gallbladder mucosal ablation.


The purpose of gallbladder ablation is to induce scarring down of the gallbladder (i.e. functional cholecystectomy). This can be confirmed with a follow-up endoscopy or by radiographic (e.g. oral contrast study) or nuclear medicine study (e.g. biliary scintigraphy or HIDA study).


Aspects of the invention relate to a surgical kit or kits that contain all the additional, specialized surgical tools used to perform the tasks described above. For example, surgical kits of the invention at least include a parent magnet as described herein, and one or more daughter magnets as described herein, loaded into an introduction device such as a biliary catheter or an endoscopic instrument (e.g., EUS FNA needle and/or system). In one embodiment, the kit(s) of the invention include, but are not be limited to, (i) the parent magnet in a suitable biocompatible enclosure (e.g., Parylene or biocompatible plastic) and (ii) the daughter magnet material, preloaded for deployment. Optionally, the kit(s) of the invention include a grasping snare or pinchers for assisting with the introduction and placement of the parent and/or daughter magnets.


For embodiments or situations in which the daughter magnet or magnetic material is injected directly into the gallbladder (either by transgastric means or via the small intestine wall), the daughter magnetic material may be preloaded in an EUS FNA injection needle with an outer diameter in the range of 10 Gauge to 25 Gauge, but more preferably in the range of 15 Gauge to 20 Gauge. Deployment of both magnets into the gallbladder and/or stomach can be achieved with the aid of EUS FNA is this instance.


It should be noted that the present invention is not limited to the clinical applications listed in the afore-described disclosure. The technology as per the disclosed description may also be utilized to achieve an anastomosis between other adjacent organs in both the upper and lower gastrointestinal tracts such as, but not limited to, between the small intestine/gallbladder, the stomach/duodenum and the ileum/colon for bariatric/metabolic purposes. The daughter and parent magnet components may be delivered during simultaneous endoscopy and colonoscopy procedures and mated under fluoroscopy. The afore-mentioned endoscopy and colonoscopy procedures are well known to persons skilled in the art of therapeutic endoscopy.


While the invention has been described with respect to certain embodiments, the embodiments are intended to be exemplary, rather than limiting. Modifications and changes may be made within the scope of the appended claims.

Claims
  • 1. A kit for creating a compression anastomosis between a gallbladder and an adjacent organ, comprising: an endoscopic retrograde cholangiopancreatography guidewire;a syringe;a parent magnet adapted for placement in the adjacent organ, being sized to fit within an introducing instrument and adapted to create a compression anastomosis, the parent magnet comprising an assembly of magnetic segments associated with one another, each of the magnetic segments having opposing poles and directly joined to an immediately adjacent magnetic segment at one of the opposing poles, the assembly configured to transition between a delivery configuration and a deployed configuration; wherein, when in the delivery configuration, the magnetic segments are aligned end-to-end in a single-file arrangement and the assembly is substantially linear; and wherein, when in the deployed configuration, the magnetic segments self-assemble into a geometric shape based, at least in part, on an attractive force between immediately adjacent magnetic segments;one or more second magnets or magnetic materials adapted for placement in the gallbladder, to be attracted to the parent magnet to form a daughter magnet; anda biliary catheter disposed over the endoscopic retrograde cholangiopancreatography guidewire and pre-loaded with the one or more second magnets or magnetic materials within the biliary catheter and configured for introducing the biliary catheter over the endoscopic retrograde cholangiopancreatography guidewire into the gallbladder and delivering the one or more second magnets or magnetic materials to the gallbladder via the biliary catheter using air pressure or liquid pressure from the syringe, wherein the parent magnet and the one or more second magnets or magnetic materials are made of or coated with biocompatible materials, and wherein the parent magnet is a different shape or size than the daughter magnet and is adapted for delivery using a different type of instrument than the biliary catheter.
  • 2. The kit of claim 1, wherein the introducing instrument comprises an endoscope.
  • 3. The kit of claim 1, wherein the biliary catheter has an outer diameter in the range of 10 Gauge to 25 Gauge.
  • 4. The kit of claim 3, wherein the biliary catheter has an outer diameter in the range of 15 Gauge to 20 Gauge.
  • 5. The kit of claim 1, wherein at least one of: the parent magnet further comprises a tissue attaching structure.
  • 6. The kit of claim 5, wherein the tissue-attaching structure comprises a clip.
  • 7. The kit of claim 1, wherein the one or more second magnets or magnetic materials comprise a plurality of ball-bearings.
  • 8. The kit of claim 1, wherein the one or more second magnets or magnetic materials are further adapted to self-assemble into a larger magnetic structure upon introduction into the gallbladder.
  • 9. The kit of claim 1, wherein the one or more second magnets or magnetic materials comprise a magnetic slurry or paste.
  • 10. The kit of claim 1, wherein at least one of the magnetic segments is directly joined to an immediately adjacent magnetic segment by way of a mechanical connection.
  • 11. The kit of claim 10, wherein the mechanical connection comprises a hinge assembly allowing rotation of adjacent magnetic segments relative to one another.
  • 12. The kit of claim 11, wherein the hinge assembly comprises one or more knuckles defined on corresponding ends of adjacent magnetic segments and configured to cooperatively engage one another and allow rotation of the adjacent magnetic segments relative to one another.
  • 13. The kit of claim 1, wherein at least one of the magnetic segments is directly joined to an immediately adjacent magnetic segment by way of an attractive magnetic force.
  • 14. The kit of claim 1, wherein the geometric shape is angular, polygonal, annular, or spiral.
  • 15. The kit of claim 1, wherein, when in the deployed configuration, a most-distal magnetic segment of the delivery configuration and a most-proximal magnetic segment of the delivery configuration are directly joined to one another.
REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/350,519, filed Nov. 14, 2016 (now U.S. Pat. No. 10,448,954), which is a continuation of U.S. application Ser. No. 14/449,414, filed Aug. 1, 2014 (now U.S. Pat. No. 9,492,173), which is a continuation of U.S. application Ser. No. 12/984,803, filed Jan. 5, 2011 (now U.S. Pat. No. 8,828,032), which claims priority to U.S. Provisional Application No. 61/292,313, filed Jan. 5, 2010, the contents of each of which are incorporated herein by reference herein in their entirety.

GOVERNMENT SUPPORT

This invention was made with government support under W81XWH-07-2-0011 awarded by U.S. Army Medical Research Acquisition Activity (USAMRAA), the contracting support element of U.S. Army Medical Research and Materiel Command (USAMRMC), which is the medical research program coordinator for the Department of Defense (DOD). The government has certain rights in the invention.

US Referenced Citations (187)
Number Name Date Kind
4197840 Beck et al. Apr 1980 A
4538130 Gluckstern et al. Aug 1985 A
5300910 Unkelbach et al. Apr 1994 A
5381784 Adair Jan 1995 A
5431670 Holmes Jul 1995 A
5595562 Grier Jan 1997 A
5690656 Cope et al. Nov 1997 A
6129668 Haynor et al. Oct 2000 A
6132458 Staehle et al. Oct 2000 A
6190303 Glenn et al. Feb 2001 B1
6273895 Pinchuk et al. Aug 2001 B1
6352543 Cole Mar 2002 B1
6371964 Vargas et al. Apr 2002 B1
6478210 Adams et al. Nov 2002 B2
6632229 Yamanouchi et al. Oct 2003 B1
6652540 Cole et al. Nov 2003 B1
6699263 Cope Mar 2004 B2
6719768 Cole et al. Apr 2004 B1
6802847 Carson Oct 2004 B1
6827718 Hutchins et al. Dec 2004 B2
6932827 Cole Aug 2005 B2
7282057 Surti et al. Oct 2007 B2
7618427 Oritz et al. Nov 2009 B2
7641638 Waxman et al. Jan 2010 B2
7760059 Higuchi Jul 2010 B2
7909837 Crews et al. Mar 2011 B2
8043290 Harrison et al. Oct 2011 B2
8118821 Mouw Feb 2012 B2
8142454 Harrison et al. Mar 2012 B2
8262680 Swain et al. Sep 2012 B2
8439915 Harrison et al. May 2013 B2
8506516 Kassab et al. Aug 2013 B2
8518062 Cole et al. Aug 2013 B2
8556919 Aguirre et al. Oct 2013 B2
8603121 Surti et al. Dec 2013 B2
8623036 Harrison et al. Jan 2014 B2
8679139 Aguirre et al. Mar 2014 B2
8685046 Viola Apr 2014 B2
8728105 Aguirre May 2014 B2
8794243 Deem et al. Aug 2014 B2
8828031 Fox et al. Sep 2014 B2
8828032 McWeeney et al. Sep 2014 B2
8845663 Chmura Sep 2014 B2
8864781 Surti et al. Oct 2014 B2
8870899 Beisel et al. Oct 2014 B2
8915915 Harrison et al. Dec 2014 B2
9168041 Zaritsky et al. Oct 2015 B2
9226753 Surti et al. Jan 2016 B2
9320524 Gagner et al. Apr 2016 B2
9421015 Gagner et al. Aug 2016 B2
9456820 Gagner et al. Oct 2016 B2
9492173 McWeeney Nov 2016 B2
9539010 Gagner et al. Jan 2017 B2
9763664 Beisel et al. Sep 2017 B2
9801635 Gagner et al. Oct 2017 B2
9877724 Gagner et al. Jan 2018 B2
9943335 Gittard et al. Apr 2018 B2
10039550 Altman Aug 2018 B2
10159487 Gagner et al. Dec 2018 B2
10182821 Lukin et al. Jan 2019 B2
10285703 Viola May 2019 B2
10342544 Bakos et al. Jul 2019 B2
10376400 McGuckin, Jr. Aug 2019 B2
10448954 McWeeney Oct 2019 B2
10517600 Beisel et al. Dec 2019 B2
10555735 Bakos et al. Feb 2020 B2
10568630 Hernandez et al. Feb 2020 B2
10595869 Beisel et al. Mar 2020 B2
10624643 Hunt et al. Apr 2020 B2
10624644 Bakos et al. Apr 2020 B2
10631865 Bakos et al. Apr 2020 B2
10667817 Gagner et al. Jun 2020 B2
10682143 Hernandez et al. Jun 2020 B2
10779831 Lukin et al. Sep 2020 B2
10813642 Beisel et al. Oct 2020 B2
10952732 Binmoeller et al. Mar 2021 B2
11039838 Binmoeller et al. Jun 2021 B2
11311298 Gagner et al. Apr 2022 B2
11432873 Brown et al. Sep 2022 B2
20020055674 Ben-Haim et al. May 2002 A1
20020143347 Cole et al. Oct 2002 A1
20030149422 Muller Aug 2003 A1
20030176767 Long et al. Sep 2003 A1
20040034377 Sharkawy et al. Feb 2004 A1
20050020958 Paolini et al. Jan 2005 A1
20050080439 Carson et al. Apr 2005 A1
20050256503 Hall Nov 2005 A1
20050277966 Ewers et al. Dec 2005 A1
20050283235 Kugler et al. Dec 2005 A1
20060036267 Saadat et al. Feb 2006 A1
20060271107 Harrison et al. Nov 2006 A1
20060282106 Cole et al. Dec 2006 A1
20070106312 Vargas et al. May 2007 A1
20070276378 Harrison et al. Nov 2007 A1
20080051626 Sato et al. Feb 2008 A1
20080086192 WasDyke et al. Apr 2008 A1
20080114384 Chang et al. May 2008 A1
20080183272 Wood et al. Jul 2008 A1
20080200933 Bakos et al. Aug 2008 A1
20080200934 Fox Aug 2008 A1
20080208105 Zelickson et al. Aug 2008 A1
20080208224 Surti Aug 2008 A1
20080262523 Makower et al. Oct 2008 A1
20090048618 Harrison et al. Feb 2009 A1
20090062824 Berg et al. Mar 2009 A1
20090125042 Mouw May 2009 A1
20090227828 Swain et al. Sep 2009 A1
20100010508 Takahashi et al. Jan 2010 A1
20100010610 Grevious Jan 2010 A1
20100036399 Viola Feb 2010 A1
20100056861 Spivey Mar 2010 A1
20100099947 Sato et al. Apr 2010 A1
20100179510 Fox et al. Jul 2010 A1
20110009886 Gagner et al. Jan 2011 A1
20110098731 Whitbrook et al. Apr 2011 A1
20110144560 Gagner et al. Jun 2011 A1
20110160751 Granja Filho Jun 2011 A1
20110160752 Aguirre Jun 2011 A1
20110295055 Albrecht et al. Dec 2011 A1
20110295285 McWeeney et al. Dec 2011 A1
20120022572 Braun et al. Jan 2012 A1
20120197062 Requarth Aug 2012 A1
20120238796 Conlon Sep 2012 A1
20120259350 Gagner et al. Oct 2012 A1
20120330330 Gagner et al. Dec 2012 A1
20130009886 Wu et al. Jan 2013 A1
20130138126 Gagner et al. May 2013 A1
20130150873 Gagner et al. Jun 2013 A1
20130253548 Harrison et al. Sep 2013 A1
20130253550 Beisel et al. Sep 2013 A1
20130325042 Fabian et al. Dec 2013 A1
20140018824 Julian et al. Jan 2014 A1
20140019468 Federoff et al. Jan 2014 A1
20140066709 Mirza et al. Mar 2014 A1
20140188246 Aronson et al. Jul 2014 A1
20140194689 Carrillo, Jr. et al. Jul 2014 A1
20140236064 Binmoeller et al. Aug 2014 A1
20140303657 Kim et al. Oct 2014 A1
20140309669 Fabian et al. Oct 2014 A1
20140309670 Bakos et al. Oct 2014 A1
20140343583 McWeeney et al. Nov 2014 A1
20140379065 Johnson et al. Dec 2014 A1
20150057687 Gittard et al. Feb 2015 A1
20150164508 Hernandez et al. Jun 2015 A1
20150182224 Altman Jul 2015 A1
20160022266 Lukin et al. Jan 2016 A1
20160235442 Palese et al. Aug 2016 A1
20160262761 Beisel et al. Sep 2016 A1
20160287257 Fabian et al. Oct 2016 A1
20160324523 Lukin et al. Nov 2016 A1
20160367236 Leeflang et al. Dec 2016 A1
20160374683 Gagner et al. Dec 2016 A1
20170035425 Fegelman et al. Feb 2017 A1
20170265866 Ryou et al. Sep 2017 A1
20180028186 Yamanouchi Feb 2018 A1
20180028187 Gagner et al. Feb 2018 A1
20180193061 Gittard et al. Jul 2018 A1
20180214149 Hunt et al. Aug 2018 A1
20180214150 Bakos et al. Aug 2018 A1
20180214152 Bakos et al. Aug 2018 A1
20180263625 Lukin et al. Sep 2018 A1
20180296218 Binmoeller et al. Oct 2018 A1
20180361127 Gray et al. Dec 2018 A1
20190133587 Gagner et al. May 2019 A1
20190133678 Pate et al. May 2019 A1
20190183507 Baillargeon Jun 2019 A1
20190216460 Kopelman Jul 2019 A1
20190261998 Altman et al. Aug 2019 A1
20190274687 Wang et al. Sep 2019 A1
20200008834 Cauche et al. Jan 2020 A1
20200129283 Swensgard et al. Apr 2020 A1
20200138438 Harrison et al. May 2020 A1
20200187947 Hernandez et al. Jun 2020 A1
20200229968 Galloway Jul 2020 A1
20200246009 Gagner et al. Aug 2020 A1
20200323530 Sharma Oct 2020 A1
20210100554 Seddon et al. Apr 2021 A1
20210161532 Beisel et al. Jun 2021 A1
20210169485 Beisel et al. Jun 2021 A1
20210169486 Gagner et al. Jun 2021 A1
20210244414 Lukin et al. Aug 2021 A1
20220087678 Gagner et al. Mar 2022 A1
20230165585 McWeeney et al. Jun 2023 A1
20230172608 Lukin et al. Jun 2023 A1
20230190269 Tinkham et al. Jun 2023 A1
20230255624 Wallace et al. Aug 2023 A1
20230389923 Tinkham et al. Dec 2023 A1
Foreign Referenced Citations (40)
Number Date Country
3011742 Oct 1981 DE
1894514 Mar 2008 EP
1493391 Dec 2009 EP
2207488 Sep 2012 EP
2538852 Jan 2013 EP
3267905 Jan 2018 EP
2260752 Mar 2018 EP
3573542 Dec 2019 EP
3487418 Apr 2020 EP
2003530916 Oct 2003 JP
2006271832 Oct 2006 JP
2008508939 Mar 2008 JP
2011500159 Jan 2011 JP
2015139592 Aug 2015 JP
2017521223 Aug 2017 JP
202198077 Jul 2021 JP
2 018 266 Aug 1994 RU
1708313 Jan 1992 SU
1 725 851 Apr 1992 SU
01087398 Nov 2001 WO
0193920 Dec 2001 WO
2009048954 Apr 2009 WO
2011085006 Jul 2011 WO
2011103400 Aug 2011 WO
2013009886 Jan 2013 WO
2013176993 Nov 2013 WO
2014055193 Apr 2014 WO
2016082481 Jun 2016 WO
2016145414 Sep 2016 WO
2018022180 Feb 2018 WO
2018138632 Aug 2018 WO
2019077218 Apr 2019 WO
2019232526 Dec 2019 WO
2019232527 Dec 2019 WO
2020196336 Oct 2020 WO
2021203910 Oct 2021 WO
2021207821 Oct 2021 WO
2022061117 Mar 2022 WO
2022132351 Jun 2022 WO
2022171349 Aug 2022 WO
Non-Patent Literature Citations (22)
Entry
International Search Report for PCT/US2013/041641 dated Oct. 18, 2013, 4 pages.
International Search Report for International application No. PCT/US2011/020229, with a date of mailing of the International search report dated Jun. 21, 2013, 6 pages.
Partial and Extended European Search Report for 13793804.9 dated Jan. 15, 2016, 9 pages.
Search Report and Written Opinion issued for PCT/US2015/041498 dated Nov. 17, 2015, 17 pages.
Search Report and Written Opinion issued for PCT/US2016/031547 dated Oct. 18, 2016, 18 pages.
European Patent Office, Communication pursuant to Article 94(3) EPC for Application No. 19810895.3, dated Feb. 13, 2023 (3 pages).
Extended European Search Report of the European Patent Office, Application No. 19810895.3, dated Feb. 7, 2022, 10 pages.
Gagner, M., “Duodeno-Ileal Anastomosis with Self-Assembling Magnets: Initial Concepts and Basis of This Operation”, Obesity Surgery 32, 932-933 (2022).
International Search Report and Written Opinion of the International Searching Authority, Application No. PCT/US2019035202, dated Aug. 8, 2019, 6 pages.
International Search Report and Written Opinion of the International Searching Authority, Application No. PCT/US2022/25343, dated Jul. 18, 2022, 14 pages.
International Search Report and Written Opinion of the International Searching Authority, Application No. PCT/US2022/25353, dated Jun. 30, 2022, 12 pages.
International Search Report and Written Opinion of the International Searching Authority, for Application PCT/US2016/022209, dated May 30, 2016.
International Search Report and Written Opinion of the International Searching Authority, for Application PCT/US22/25338, dated Aug. 19, 2022, 14 pages.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, from the International Search Authority, Application No. PCT/US2022/025338, mailed Jun. 23, 2022, 2 pages.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, from the International Search Authority, Application No. PCT/US2022/025370, mailed Jun. 24, 2022, 3 pages.
Japanese Office Action for Japanese Patent Application No. 2021-034336 dated Dec. 17, 2021, 3 pages.
Japanese Office Action, Notice of Reasons for Refusal, Japanese Patent Application No. 2020-567134 dated Feb. 21, 2023.
Japanese Penultimate Office Action for Japanese Patent Application No. 2021-034336 dated Aug. 1, 2022, 9 pages.
Japanese Search Report, Japanese Application No. 2020-567134, dated Feb. 13, 2023, 28 pages.
Author Unknown, “An Innovative Implant for the Creation of Anastomosis,” PLIO, retrieved from the internet at: https://pliosurgical.com/, Jan. 19, 2024 (13 pages).
International Search Report and Written Opinion of the International Searching Authority, for Application PCT/US23/29416, dated Dec. 7, 2023, 9 pages.
International Search Report and Written Opinion of the International Searching Authority, for Application PCT/US23/29432, dated Nov. 14, 2023, 7 pages.
Related Publications (1)
Number Date Country
20200222049 A1 Jul 2020 US
Provisional Applications (1)
Number Date Country
61292313 Jan 2010 US
Continuations (3)
Number Date Country
Parent 15350519 Nov 2016 US
Child 16600841 US
Parent 14449414 Aug 2014 US
Child 15350519 US
Parent 12984803 Jan 2011 US
Child 14449414 US